Blueberries Medical Corp.

CNSX: BBM


Canadian symbol: BBM.CN
US symbol: BBRRF

Currency in CAD

Valuation Measures4

Market Cap (intraday) 5.46M
Enterprise Value 6.24M
Trailing P/E 7.77
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)15.97
Price/Book (mrq)7.45
Enterprise Value/Revenue 20.32
Enterprise Value/EBITDA -9.79

Trading Information

Stock Price History

Beta (5Y Monthly) 1.49
52-Week Change 3-28.57%
S&P500 52-Week Change 316.57%
52 Week High 30.0450
52 Week Low 30.0000
50-Day Moving Average 30.0217
200-Day Moving Average 30.0225

Share Statistics

Avg Vol (3 month) 354.02k
Avg Vol (10 day) 333.38k
Shares Outstanding 5218.31M
Implied Shares Outstanding 6218.31M
Float 8128.01M
% Held by Insiders 168.53%
% Held by Institutions 10.00%
Shares Short (Aug 14, 2023) 443.96k
Short Ratio (Aug 14, 2023) 40.81
Short % of Float (Aug 14, 2023) 4N/A
Short % of Shares Outstanding (Aug 14, 2023) 40.02%
Shares Short (prior month Jul 13, 2023) 450k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:10
Last Split Date 3Jul 03, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2022
Most Recent Quarter (mrq)Jun 29, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-394.76%

Management Effectiveness

Return on Assets (ttm)-27.65%
Return on Equity (ttm)-220.67%

Income Statement

Revenue (ttm)307.07k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)68.90%
Gross Profit (ttm)-17.72k
EBITDA -1.07M
Net Income Avi to Common (ttm)-1.23M
Diluted EPS (ttm)-0.0100
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)790.95k
Total Cash Per Share (mrq)0
Total Debt (mrq)1.57M
Total Debt/Equity (mrq)214.79%
Current Ratio (mrq)1.00
Book Value Per Share (mrq)0.00

Cash Flow Statement

Operating Cash Flow (ttm)-1.4M
Levered Free Cash Flow (ttm)-1.72M

mrq = Most Recent Quarter
ttm = Trailing Twelve Months
yoy = Year Over Year
lfy = Last Fiscal Year
fye = Fiscal Year Ending
fy = Forward Year
Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.

Fundamentals are updated every day.
Full screen




Cannabis Market and Business News

Real-time cannabis business news from hundreds of sources. Never miss the news that matters the most.




Company News Date
BBM.CN
Blueberries Medical
4 months ago
BBM.CN
Blueberries Medical
5 months ago
BBM.CN
Blueberries Medical
10 months ago
BBM.CN
Blueberries Medical
1 year ago
BBM.CN
Blueberries Medical
1 year ago
BBM.CN
Blueberries Medical
1 year ago
BBM.CN
Blueberries Medical
2 years ago
BBM.CN
Blueberries Medical
2 years ago
BBM.CN
Blueberries Medical
3 years ago
BBM.CN
Blueberries Medical
3 years ago
BBM.CN
Blueberries Medical
3 years ago
BBM.CN
Blueberries Medical
3 years ago
BBM.CN
Blueberries Medical
3 years ago
BBM.CN
Blueberries Medical
3 years ago
BBM.CN
Blueberries Medical
3 years ago
BBM.CN
Blueberries Medical
3 years ago
BBM.CN
Blueberries Medical
3 years ago
BBM.CN
Blueberries Medical
4 years ago
BBM.CN
Blueberries Medical
4 years ago
BBM.CN
Blueberries Medical
4 years ago
BBM.CN
Blueberries Medical
4 years ago
BBM.CN
Blueberries Medical
4 years ago
BBM.CN
Blueberries Medical
4 years ago
BBM.CN
Blueberries Medical
4 years ago
BBM.CN
Blueberries Medical
4 years ago
BBM.CN
Blueberries Medical
4 years ago
BBM.CN
Blueberries Medical
4 years ago
BBM.CN
Blueberries Medical
4 years ago
BBM.CN
Blueberries Medical
4 years ago
BBM.CN
Blueberries Medical
4 years ago
BBM.CN
Blueberries Medical
4 years ago
BBM.CN
Blueberries Medical
4 years ago
BBM.CN
Blueberries Medical
4 years ago
BBM.CN
Blueberries Medical
4 years ago
BBM.CN
Blueberries Medical
4 years ago
BBM.CN
Blueberries Medical
4 years ago
BBM.CN
Blueberries Medical
4 years ago
BBM.CN
Blueberries Medical
4 years ago
BBM.CN
Blueberries Medical
4 years ago
BBM.CN
Blueberries Medical
4 years ago

Analysts data is not available


Insiders transactions are updated every hour.

Major Holders

Currency in CAD
Breakdown
68.53%% of Shares Held by All Insider
0.00%% of Shares Held by Institutions
0.00%% of Float Held by Institutions
0Number of Institutions Holding Shares
Coming Soon

Search SEDAR Filings

Company Name:
Document Type:
Start Date:
End Date:

Press Releases by Blueberries Medical Corp.


Blueberries Medical Announces Closing of US$1.1 Million Non-Brokered Private Placement, reports 2022 Q3 Financial Results and provides Corporate and Operations Update

Blueberries Medical Announces Closing of US$1.1 Million Non-Brokered Private Placement, reports 2022 Q3 Financial Results and provides Corporate and Operations Update

TORONTO, Nov. 28, 2022 -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or “Blueberries”), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, announces the completion of a non-brokered private placement consisting of the sale of 54,498,889 common shares (“Common Shares”) a... Read More...
Blueberries Medical Reports 2022 Q2 Financial Results and Provides Corporate and Operations Update

Blueberries Medical Reports 2022 Q2 Financial Results and Provides Corporate and Operations Update

TORONTO, Aug. 25, 2022 -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA), the Canadian parent of Blueberries S.A.S. (“BBSAS”), the premier Latin American licensed cultivator and producer of medicinal cannabis and medicinal-grade cannabis extracts, (together the “Company” or "Blueberries"), is pleased to report its financial ... Read More...
Blueberries Medical Announces the launch of new markets for its products, partnerships in agronomic operation and the Extension of Maturity Date of Convertible Debenture

Blueberries Medical Announces the launch of new markets for its products, partnerships in agronomic operation and the Extension of Maturity Date of Convertible Debenture

TORONTO, July 29, 2022 -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, announces that has achieved several CBD and non-psychoactive derivatives shipments to customers in Argentina, and up to date has ex... Read More...
Blueberries Medical Reports 2022 Q1 Financial Results and Provides Corporate and Operations Update

Blueberries Medical Reports 2022 Q1 Financial Results and Provides Corporate and Operations Update

TORONTO, May 30, 2022 -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA), the Canadian parent of Blueberries S.A.S. (“BBSAS”), the premier Latin American licensed cultivator and producer of medicinal cannabis and medicinal-grade cannabis extracts, (together the “Company” or "Blueberries"), is pleased to report its financial r... Read More...
Blueberries Medical Reports 2021 Q3 Financial Results and Provides Corporate and Operations Update

Blueberries Medical Reports 2021 Q3 Financial Results and Provides Corporate and Operations Update

TORONTO, Nov. 29, 2021 -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA), the Canadian parent of Blueberries S.A.S. (“BBSAS”), the premier Latin American licensed cultivator and producer of medicinal cannabis and medicinal-grade cannabis extracts, (together the “Company” or "Blueberries"), is pleased to report its financial ... Read More...
Blueberries Medical Corp Announces that its subsidiary Blueberries SAS has obtained the qualification as Breeding Unit and Exporter of Selected Seeds

Blueberries Medical Corp Announces that its subsidiary Blueberries SAS has obtained the qualification as Breeding Unit and Exporter of Selected Seeds

TORONTO, Oct. 20, 2021 -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the "Company" or "Blueberries"), a licensed Latin American producer of medical Cannabis and Cannabis-derived products, today announces that its wholly owned subsidiary Blueberries S.A.S. in Bogota, Colombia, obtained the registration of its agronomic o... Read More...
Blueberries Medical Announces that its wholly subsidiary Blueberries SAS at Bogota, Colombia has made one of the biggest exports of Premium CBD Full Spectrum Oil of all time, scaling up its business to a level that will improve life condition of more than 2.500 patients in Peru

Blueberries Medical Announces that its wholly subsidiary Blueberries SAS at Bogota, Colombia has made one of the biggest exports of Premium CBD Full Spectrum Oil of all time, scaling up its business to a level that will improve life condition of more than 2.500 patients in Peru

TORONTO, Oct. 04, 2021 -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, today announced its wholly owned subsidiary Blueberries SAS has exported a total of 150 kg of premium CBD 5% Full Spectrum Oil to F... Read More...
Blueberries Announces Webcast Instructions for its Annual General and Meeting (“AGM”)

Blueberries Announces Webcast Instructions for its Annual General and Meeting (“AGM”)

TORONTO, Sept. 22, 2021 -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce webcast link for the Annual General Meeting of the shareholders of Blueberries Medical Corp. (the “AGM” or ... Read More...
Blueberries Medical Announces Closing of C$ 2.1 Million Non-Brokered Private Placement and the Appointment of New Director

Blueberries Medical Announces Closing of C$ 2.1 Million Non-Brokered Private Placement and the Appointment of New Director

TORONTO, Sept. 09, 2021 -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, announces the completion of a non-brokered private placement consisting of the sale of 20,813,817 common shares (“Common Shares”) ... Read More...
Blueberries Medical Reports 2021 Q2 Financial Results and Provides Corporate and Operations Update

Blueberries Medical Reports 2021 Q2 Financial Results and Provides Corporate and Operations Update

TORONTO, Aug. 30, 2021 -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) the Canadian parent of Blueberries S.A.S. (“BBSAS”), the premier Latin American licensed cultivator and producer of medicinal cannabis and medicinal-grade cannabis extracts, (together the “Company” or "Blueberries"), is pleased to report its financial r... Read More...
Blueberries Medical Reports 2021 Q1 Financial Results and Provides Corporate and Operations Update

Blueberries Medical Reports 2021 Q1 Financial Results and Provides Corporate and Operations Update

TORONTO, May 31, 2021 -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) the Canadian parent of Blueberries S.A.S. (“BBSAS”), the premier Latin American licensed cultivator and producer of medicinal cannabis and medicinal-grade cannabis extracts, (together the “Company” or "Blueberries"), is pleased to report its financial re... Read More...
Blueberries Medical Signs Framework Agreement with YVY Life Sciences of Uruguay

Blueberries Medical Signs Framework Agreement with YVY Life Sciences of Uruguay

TORONTO, March 26, 2021 -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) the Canadian parent of Blueberries S.A.S., the premier Latin American licensed cultivator and producer of medicinal cannabis and medicinal-grade cannabis extracts, (together the “Company” or “Blueberries”), today announced that it has signed a Framewor... Read More...
Blueberries Medical Enters Growing Peruvian Medical Cannabis Market: Enters Binding LOI with Futura Farms

Blueberries Medical Enters Growing Peruvian Medical Cannabis Market: Enters Binding LOI with Futura Farms

TORONTO, March 15, 2021 -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, today announced its wholly owned subsidiary Blueberries SAS will supply premium, formulated cannabis oil to Futura Farms, a licens... Read More...
Blueberries Medical Appoints Former Clever Leaves Global Head of B2B as President of Latin American Operations

Blueberries Medical Appoints Former Clever Leaves Global Head of B2B as President of Latin American Operations

TORONTO, Feb. 10, 2021 -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce the appointment of José María Forero, the former Global Head of B2B of Clever Leaves Holdings Inc. (NASDAQ: ... Read More...
Blueberries Medical Closes $1M Strategic Financing Led by a Leading Latin American Private Equity Group with Extensive International Cannabis Industry Expertise; Appoints Facundo Garretón as Chairman & Interim CEO

Blueberries Medical Closes $1M Strategic Financing Led by a Leading Latin American Private Equity Group with Extensive International Cannabis Industry Expertise; Appoints Facundo Garretón as Chairman & Interim CEO

TORONTO, Jan. 20, 2021 -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce the completion of a non-brokered private placement for aggregate gross proceeds of C$1,000,000 (the “Offerin... Read More...
Blueberries Medical Announces Closing of the Acquisition of BBV Labs – A Milestone in its Argentina Project

Blueberries Medical Announces Closing of the Acquisition of BBV Labs – A Milestone in its Argentina Project

TORONTO, Dec. 04, 2020 -- Further to its news releases dated March 26, April 4, and July 2, 2019, Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and cannabis-derived products is pleased to announce that the Company has completed the ac... Read More...
Blueberries Medical Announces Approval of Nine Psychoactive Strains, Corporate Update

Blueberries Medical Announces Approval of Nine Psychoactive Strains, Corporate Update

TORONTO, Oct. 26, 2020 -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and cannabis-derived products announced today that the Company received approval from the Colombian Agricultural Institute (“ICA”) for the registration of its nin... Read More...
Blueberries Announces Call-in and Webcast Details for its Annual General and Special Meeting (“AGM”)

Blueberries Announces Call-in and Webcast Details for its Annual General and Special Meeting (“AGM”)

TORONTO, July 24, 2020 -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce call-in numbers and webcast link for the Annual General and Special Meeting of the shareholders of Blueberri... Read More...
Blueberries Announces Strategic Investor & Closing of $1.0 Million Financing

Blueberries Announces Strategic Investor & Closing of $1.0 Million Financing

TORONTO, July 16, 2020 -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce it has closed a non-brokered private placement offering (the “Offering”) of C$1,000,000 in principal amount ... Read More...
Blueberries Commences Commercial Sales of Proprietary Cultivars to Local Partners

Blueberries Commences Commercial Sales of Proprietary Cultivars to Local Partners

TORONTO, June 02, 2020 -- Blueberries Medical Corp. (CSE:BBM) (BBRRF) (1OA.F) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce that it has officially commenced sales of its proprietary cultivars approved by the Colombian Institute of Agricultur... Read More...
Blueberries Medical Announces Joint Venture with QualCann SAS to Export to the US Market

Blueberries Medical Announces Joint Venture with QualCann SAS to Export to the US Market

TORONTO, May 05, 2020 -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce that the Company has entered into a Joint Venture (the “JV”) with QualCann SAS (“QualCann”), an arm’s length ... Read More...
Blueberries Medical Granted Cultivation License for up to 37 Acres of Outdoor Production at Second Cultivation Property, Signs Letter of Intent to Commence Low-Cost Outdoor Production

Blueberries Medical Granted Cultivation License for up to 37 Acres of Outdoor Production at Second Cultivation Property, Signs Letter of Intent to Commence Low-Cost Outdoor Production

TORONTO, April 23, 2020 -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce that the Ministry of Justice and Law of the Republic of Colombia has granted a non-psychoactive cultivation... Read More...
Blueberries Medical Appoints Co-Founder Camilo Villalba as CEO, Exports Expected to Commence in First Half of 2020

Blueberries Medical Appoints Co-Founder Camilo Villalba as CEO, Exports Expected to Commence in First Half of 2020

TORONTO, Dec. 16, 2019 -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the "Company" or "Blueberries"), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce that the Board of Directors has appointed Mr. Camilo Villalba as Chief Executive Officer of the Company. Mr.... Read More...
Blueberries Medical Harvests First Commercial Crop & Progresses Towards Expected Sales in Early 2020

Blueberries Medical Harvests First Commercial Crop & Progresses Towards Expected Sales in Early 2020

TORONTO, Dec. 03, 2019 -- Blueberries Medical Corp. (BBM.CN) (BBRRF) (1OA.F) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce that it has commenced harvest of its first commercial crops at its 3.2-hectare Guatavita facility located in Bogotá Sa... Read More...
Blueberries Medical Partners with 12,000 Patient Health Clinic and Renowned Academic Foundation and Announces Final Closing of Over-Subscribed Private Placement

Blueberries Medical Partners with 12,000 Patient Health Clinic and Renowned Academic Foundation and Announces Final Closing of Over-Subscribed Private Placement

TORONTO, Oct. 31, 2019 -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a leading Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce that the Company has partnered with the Van Uden International Center for Alternative Medicine (“Van... Read More...
Blueberries Medical Receives Approval for Commercial Production & Registration of Five Proprietary CBD Cultivars from the Colombian Institute of Agriculture

Blueberries Medical Receives Approval for Commercial Production & Registration of Five Proprietary CBD Cultivars from the Colombian Institute of Agriculture

TORONTO, Sept. 27, 2019 -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce that the Company has received approval from the Colombian Institute of Agriculture (“ICA”) for the registra... Read More...
Blueberries Medical and The Colombian Society of Pediatrics Partner to Host Medicinal Cannabis Seminar in Bogota

Blueberries Medical and The Colombian Society of Pediatrics Partner to Host Medicinal Cannabis Seminar in Bogota

TORONTO, Sept. 18, 2019 -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce that the Company has partnered with The Colombian Society of Pediatrics to host a full-day educational semi... Read More...
Blueberries Medical Announces Internationally Renowned Medical & Scientific Committee

Blueberries Medical Announces Internationally Renowned Medical & Scientific Committee

TORONTO, Sept. 12, 2019 -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a leading Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce the formation of its medical & scientific committee to support management in the development of... Read More...
Blueberries Medical Corp. Closes Over-Subscribed Private Placement

Blueberries Medical Corp. Closes Over-Subscribed Private Placement

Not for distribution into the United States or to U.S. newswire servicesTORONTO, Aug. 30, 2019 -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a leading Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce it has closed its over-subsc... Read More...
Blueberries Medical Announces $3 Million Non-Brokered Private Placement

Blueberries Medical Announces $3 Million Non-Brokered Private Placement

TORONTO, Aug. 12, 2019 -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a leading Latin American licensed producer of medicinal cannabis and cannabis-derived products, announces a non-brokered private placement of up to 12,000,000 units (the “Units”) at a price of C$0.25 per Unit for gross ... Read More...
Blueberries Medical Makes Significant Advances Towards Commercial Production & Provides Operational and Corporate Update

Blueberries Medical Makes Significant Advances Towards Commercial Production & Provides Operational and Corporate Update

TORONTO, July 18, 2019 -- Blueberries Medical Corp. (BBM.CN) (BBRRF) (1OA.F) (the “Company” or "Blueberries"), a leading Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to provide investors with the following update on the Company’s significant recent operational achievements and upcoming m... Read More...
Blueberries Announces DTC Eligibility of its Common Shares in the United States

Blueberries Announces DTC Eligibility of its Common Shares in the United States

TORONTO, July 04, 2019 -- Blueberries Medical Corp. (CSE: BBM) (BBRRF) (1OA.F) ("Blueberries" or the "Company"), a leading Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce that the Company’s common shares, traded in the United States under the symbol BBRRF, are now eligible for e... Read More...
Blueberries Executes Definitive Agreement to Acquire Cannabis Cultivation, Processing & Manufacturing Rights for 3.2M Square Foot Property in Argentina

Blueberries Executes Definitive Agreement to Acquire Cannabis Cultivation, Processing & Manufacturing Rights for 3.2M Square Foot Property in Argentina

TORONTO, July 02, 2019 -- Further to its news releases dated March 26 and April 4, 2019, Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a leading Colombia based licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce that the Company has entered into a d... Read More...
Blueberries and SLANG Worldwide Enter into Strategic Partnership for Colombia and Argentina

Blueberries and SLANG Worldwide Enter into Strategic Partnership for Colombia and Argentina

TORONTO, June 11, 2019 -- Blueberries Medical Corp. (CSE: BBM) (OTCQB: BBRRF) (FRA: 1OA) ("Blueberries"), a leading Latin American licensed producer of medicinal cannabis and cannabis-derived products and SLANG Worldwide Inc. (CSE: SLNG), (Frankfurt: 84S), (“SLANG”) a leading global cannabis consumer packaged goods (“CPG”) company with a ... Read More...
Blueberries Announces Cannabis Sales and Distribution Agreement for German Market

Blueberries Announces Cannabis Sales and Distribution Agreement for German Market

TORONTO, June 05, 2019 -- Blueberries Medical Corp. (CSE: BBM) (OTCQB: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a leading Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce that it has entered into a letter agreement (the "Letter Agreement") to become a strategic supplie... Read More...
Blueberries Receives Approval to Sell Five CBD Wellness Products in Colombia and Internationally from Colombian Food and Drug Regulator

Blueberries Receives Approval to Sell Five CBD Wellness Products in Colombia and Internationally from Colombian Food and Drug Regulator

TORONTO, May 13, 2019 -- Blueberries Medical Corp. (BBM.CN) (BBRRF) (1OA.F) (the “Company” or "Blueberries"), a leading Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce that the Company has received approval for the production, sale and export of five cannabidiol ("CBD") based he... Read More...
Blueberries Medical Appoints Former Abbott Laboratories/AbbVie Pharmaceutical Executive Eduardo Molinari as Chief Marketing Officer

Blueberries Medical Appoints Former Abbott Laboratories/AbbVie Pharmaceutical Executive Eduardo Molinari as Chief Marketing Officer

Strategic Hire Adds Further Latin American and International Pharmaceutical Industry Experience to Management TeamTORONTO, April 17, 2019 -- Blueberries Medical Corp. (BBM.CN) (BBRRF) (1OA.F) (the “Company” or "Blueberries") a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce the ... Read More...
Blueberries Medical to Collaborate with the International Research Center on Cannabis and Mental Health in New York for Product Formulation and the Development of Treatment-Focused Medical Education Programs

Blueberries Medical to Collaborate with the International Research Center on Cannabis and Mental Health in New York for Product Formulation and the Development of Treatment-Focused Medical Education Programs

TORONTO, April 15, 2019 -- Blueberries Medical Corp. (BBM.CN) (BBRRF) (1OA.F) (the “Company” or "Blueberries") a Latin American licenced producer of medicinal cannabis and cannabis-derived products, has signed a definitive joint venture agreement (the “Agreement”) with the International Research Center on Cannabis and Mental Health (“IRCC... Read More...
Blueberries Medical to Present at 2019 GMP Securities’ Global Cannabis Conference

Blueberries Medical to Present at 2019 GMP Securities’ Global Cannabis Conference

TORONTO, April 12, 2019 -- Blueberries Medical Corp. (BBM.CN) (BBRRF) (1OA.F) (the “Company” or "Blueberries") a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce that the Company’s executive management team will attend and present at GMP Securities’ 2019 Global Cannabis Conferenc... Read More...
Blueberries Medical Commences Formal Development Process for the Cultivation of Cannabis in Jujuy Argentina

Blueberries Medical Commences Formal Development Process for the Cultivation of Cannabis in Jujuy Argentina

TORONTO, April 04, 2019 -- Blueberries Medical Corp. (BBM.CN) (BBRRF) (1OA.F) (the “Company” or "Blueberries"), a Latin American focused licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce that it has commenced the Phase 1 planning process with Argentinian state owned cannabis company Cannabis Ava... Read More...
Blueberries Medical Commences Trading in the United States on OTCQB Market Under Symbol BBRRF

Blueberries Medical Commences Trading in the United States on OTCQB Market Under Symbol BBRRF

TORONTO, April 01, 2019 -- Blueberries Medical Corp. (BBM.CN) (BBRRF) (1OA.F) (the “Company” or "Blueberries"), a leading Colombia based licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce that its common shares will commences trading on the OTCQB Market (the “OTCQB”) today under the ticker symbol... Read More...
Blueberries Medical to Acquire Cannabis Cultivation, Processing & Manufacturing Rights for 3.2 Million Square Foot Property in Argentina

Blueberries Medical to Acquire Cannabis Cultivation, Processing & Manufacturing Rights for 3.2 Million Square Foot Property in Argentina

TORONTO, March 26, 2019 -- Blueberries Medical Corp. (BBM.CN) (BBRRF) (1OA.F) (the “Company” or "Blueberries"), a leading Colombia based licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce that the Company has entered into a binding agreement effective March 25, 2019  to acquire cannabis cultivati... Read More...
Coming Soon.
IndexLast% Change
S&P 5004,288.05--
Euro STOXX 504,159.740.36%Negative
FTSE 1007,568.620.52%Negative
Nikkei 22531,759.880.31%Negative

Delayed data (1h)
IndexLast% Change
S&P 5004,288.05--
Euro STOXX 504,159.740.36%Negative
FTSE 1007,568.620.52%Negative
Nikkei 22531,759.880.31%Negative


Share this page